Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 2: From the National Multiple Sclerosis Society Case Conference Proceedings.
Neurol Neuroimmunol Neuroinflamm
; 8(1)2021 01.
Article
in En
| MEDLINE
| ID: mdl-33434885
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukoencephalopathy, Progressive Multifocal
/
Multiple Sclerosis, Relapsing-Remitting
/
Natalizumab
/
Rituximab
/
Alemtuzumab
/
Immunologic Factors
Limits:
Female
/
Humans
Language:
En
Journal:
Neurol Neuroimmunol Neuroinflamm
Year:
2021
Document type:
Article
Country of publication:
United States